People's Journal of Scientific Research
Published December 1, 2008 | Version v1
Journal article Open

Oral submucous fibrosis - Current Concepts in Etiopathogenesis

Authors/Creators

  • 1. Department of Oral & Maxillofacial Surgery, eoples Dental Academy, Bhanpur, Bhopal-462010 (M.P.)
  • 2. Department of Oral & Maxillofacial Pathology, Peoples Dental Academy, Bhanpur, Bhopal-462010 (M.P.

Description

Oral submucous fibrosis (OSF) is now accepted globally as an Indian disease, having highest malignant potential
than any other oral premalignant lesions. The understanding of the exact role of alkaloids and other etiological agents with
respect to pathogenesis will help the management and minimize the blind clinical trials and treatment modalities. This
article provides an overview of the etiopathogenesis with stress on the recent concepts related to this chronic “Indian
Disease”.

Files

Dr. Shubhangi Mhaske - 11.pdf

Files (113.0 kB)

Name Size Download all
md5:af9ce7d10e16cf52d4fc38516202148c
113.0 kB Preview Download

Additional details

References

  • 1. Canniff JP, Batchelor JR, Dodi K, Harvey W.: HLA typing in oral submucous fibrosis. Tissue Antigen, 1985; 26:138- 142.
  • 2. Farrand P, Rowe RM, Johnston A, Murdoch H.: Prevalence, age of onset and demographic relationships of different Areca nut habits amongst children in Tower Hamlets, London. British Dental Journal, 2001; 190:150–154
  • 3. Ghom A, Mhaske S.: Premalignant lesions and conditions (Chapter 12) In: Textbook of oral pathology. 1st Edn, Jaypee Brothers Medical Publishers (P) Ltd, New Delhi , 2008; pp.194-201
  • 4. Gupta PC, Sinor PN, Bhonsle RB, Pawar VS, Mehta HC. Oral submucous fibrosis in India: a new epidermic. National Medical Journal of India, 1998;11:113–116.
  • 5. Haque MF, Harr is M, Meghji S, Barr ett AW.: Immunolocalization of cytokines and growth factors in oral submucous fibrosis. Cytokine, 1998;10:713–719.
  • 6. International Agency for Research on Cancer (IARC).: Betel-quid and areca nut chewing and some areca nut derived nitrosoamines. Lyon IARC, 2004; 85: 123–129.
  • 7. Jacob BJ, Straif K, Thomas G, Ramadas K, Mathew B, Zhang ZF, Rangaswamy S, Hashibe M.: Betel quid without tobacco as a risk factor for oral precancers. Oral Oncology, 2004; 40:697–704.
  • 8. Kuo MYP, Chen HM, Hahn LJ, Hsieh CC, Chiang CP.: Collagen biosynthesis in human OSF fibroblast cultures. Journal of Dental Research, 1995;74:1783– 1788
  • 9. Lee CH, Ko YC, Huang HL, Chao YY, Sheih TY, Lin LM.: The precancer risk of betel chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in Southern Taiwan. British Journal of Cancer, 2003; 88:366–372.
  • 10. Maher R, Lee AJ, Warnakulasuriya KA, Lewis JA, Johnson NW.: Role of areca nut in the causation of oral submucous fibrosis: a case control study in Pakistan. Journal of Oral Pathology & Medicine, 1994;23:65–69
  • 11. Meghji S, Scutt A, Harvey W, Canniff JP.: An in vitro comparison of human fibroblasts from normal and oral submucous fibrosis tissue. Archives of Oral Biology, 1987;32:213–215.
  • 12. Merchant AT, Haider SM, Fikree FF.: Increased severity of oral submucous fibrosis in young Pakistani men. British Journal of Oral Maxillofacial Surgery, 1997; 35:284–287.
  • 13. Murti PR, Bhonsle RB, Gupta PC, Daftary DK, Pindborg JJ, Metha FS.: Aetiology of oral submucous fibrosis with special reference to the role of areca nut chewing. Journal of Oral Pathology & Medicine, 1995;24:145–152.
  • 14. Murti PR, Bhonsle RB, Pindborg JJ, Daftary DK, Gupta PC, Mehta FS.: Malignant transformation rates in oral submucous fibrosis over a 17 year period. Community Dentistry & Oral Epidemiology, 1985;13:340–341.
  • 15. Paymaster JC.: Cancer of the buccal mucosa: A clinical study of 650 patients. Cancer, 1956;9:431–435.
  • 16. Pindborg JJ, Poulsen E, Zachariah J.: Oral epithelial changes in thirty Indians with oral cancer and oral submucous fibrosis. Cancer, 1967;20:1141–1146.
  • 17. Pindborg JJ, Murti PR, Bhonsle RB, Gupta PC, Daftary DK, Meth a FS.: Oral submucous fibrosis as a precancerous condition. Scandinavian Journal of Dental Research, 1984;92:224–229.
  • 18. Pindborg JJ, Sirsat SM.: Oral submucous fibrosis. Oral Surgery Oral Medicine & Oral Pathology, 1966; 22: 764–779.
  • 19. Rajalalitha P, Vali S.: Molecular pathogenesis of oral submucous fibrosis–collagen metabolic disorder. Journal Oral Pathology & Medicine, 2005;34:321– 328.
  • 20. Rajendran R.: Oral submucous fibrosis: etiology, pathogenesis and future research. Bulletin of World Health Organisation, 1994;72 (6): 985-996.
  • 22 Ranganathan K, Uma Devi M, Joshua E, Kirankumar K, Saraswathi TR.: Oral submucous fibrosis: a case control study in Chennai South India. Journal Oral Pathology & Medicine, 2004;33:274–277.
  • 23. Saeed B, Haque MF, Meghji S, Harris M.: HLA typing in oral submucous fibrosis. Journal of Dental Research, 1997;76:1024.
  • 24 Seedat HA, Van Wyk CW.: Betel nut chewing and oral submucous fibrosis in Durban. South African Medical Journal, 1988;74:572–575.
  • 25. Shah N, Sharma PP. Role of chewing and smoking haibts in the aetiology of oral submucous fibrosis (OSF): a case control study. Journal Oral Pathology & Medicine, 1998;27:475–479.
  • 26. Sinor PN, Gupta PC, Murti PR, Bhonsle RB, Daftary DK, Mehta FS, Pindborg JJ.: A case-control study of oral submucous fibrosis with special reference to the aetiologic role of areca nut. Journal Oral Pathology & Medicine, 1990;19:94–98.
  • 27. Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S.: Oral submucous fibrosis :Review on aetiology and pathogenesis. Oral Oncology, 2005; 42:561-568.
  • 28. Tsai CC, Ma RH, Shieh TY. Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis. Journal Oral Pathology & Medicine, 1999;28:59–63.
  • 29. Utsunomiya H, Tilakaratne WM, Oshiro K, Maruyama S, Suzuki M, Ida-Yonemochi H, Cheng. J, Sabu T.: Extracellular matrix remodeling in oral submucous fibrosis; its stage-specific modes revealed by immuno- histochemistry and in situ hybridization. Journal Oral Pathology & Medicine, 2005;34(8):498–507.
  • 30. Vilcek J, Palombella VJ, Henrikson-DeStefano D. Fibroblast growth factor enhancing activity of tumour necrosis factor and its relationship to other polypeptide growth factors. Journal of Experimental Medicine, 1986;163:632–643.
  • 31. Warnakulasuriya S.: Histological grading of oral epithelial dysplasia: revisited. Journal of Pathology, 2001;194:294–297
  • 32. Yang YH, Lee HY, Tung S, Shieh TY.: Epidemiological survey of oral submucous fibrosis and leukoplakia in aborigines of Taiwan. Journal Oral Pathology & Medicine, 2001;30:213–219.